2-[18F]FDG-PET/CT is a better predictor of survival than conventional CT: a prospective study of response monitoring in metastatic breast cancer

2-[18F]FDG-PET/CT is a better predictor of survival than conventional CT: a prospective study of response monitoring in metastatic breast cancer

Abstract This study aimed to compare CE-CT and 2-[18F]FDG-PET/CT for response monitoring metastatic breast cancer (MBC). The primary objective was to predict progression-free and disease-specific survival for responders vs. non-responders on CE-CT and 2-[18F]FDG-PET/CT. The secondary objective was t...

Full description

Bibliographic Details
Main Authors: Marianne Vogsen, Mohammad Naghavi-Behzad, Frederik Graae Harbo, Nick Møldrup Jakobsen, Oke Gerke, Jon Thor Asmussen, Henriette Juel Nissen, Sara Elisabeth Dahlsgaard-Wallenius, Poul-Erik Braad, Jeanette Dupont Jensen, Marianne Ewertz, Malene Grubbe Hildebrandt
Format: Article
Language:English
Published: Nature Portfolio 2023-04-01
Series:Scientific Reports
Online Access:https://doi.org/10.1038/s41598-023-32727-w

Internet

https://doi.org/10.1038/s41598-023-32727-w

Similar Items